CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Exercise or conversion | +7,989 | $0.94 | $8K | 17,901 |
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Exercise or conversion | +7,989 | $1.51 | $12K | 25,890 |
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Sale | −23,967 | $25.01 | $599K | 1,923 |
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Exercise or conversion · Employee stock option (right to buy) | −7,989 | 0 | ||
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Exercise or conversion · Employee stock option (right to buy) | −7,989 | 0 | ||
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Exercise or conversion · Employee stock option (right to buy) | −7,989 | 0 | ||
| 2018-02-26 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Shares withheld for taxes | −11,070 | $23.46 | $260K | 18,930 |
| 2018-01-24 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +3,000 | $0.94 | $3K | 12,100 |
| 2018-01-24 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −3,000 | $22.50 | $68K | 9,100 |
| 2018-01-24 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −3,000 | 26,497 | ||
| 2018-01-24 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +3,000 | $0.94 | $3K | 12,100 |
| 2018-01-24 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −3,000 | $22.50 | $68K | 9,100 |
| 2018-01-24 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −3,000 | 26,497 | ||
| 2018-01-17 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Exercise or conversion | +2,524 | $4.70 | $12K | 32,524 |
| 2018-01-17 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Sale | −2,524 | $20.00 | $50K | 30,000 |
| 2018-01-17 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Exercise or conversion · Employee stock option (right to buy) | −2,524 | 45,448 | ||
| 2018-01-17 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +2,000 | $0.94 | $2K | 9,100 |
| 2018-01-17 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −2,000 | 29,497 | ||
| 2018-01-16 | Karrels James SVP, CFO and Secretary | Exercise or conversion | +6,516 | $0.94 | $6K | 119,847 |
| 2018-01-16 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −6,516 | 0 |
Page 33 of 35 · 684 trades